Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease.

PubWeight™: 1.27‹?› | Rank: Top 10%

🔗 View Article (PMC 2655126)

Published in Neurochem Res on April 11, 2008

Authors

J Cameron Thrash1, Bruce E Torbett, Monica J Carson

Author Affiliations

1: Division of Biomedical Sciences, Center for Glial-Neuronal Interactions, University of California Riverside, 900 University Ave, Riverside, CA, 92521, USA.

Articles citing this

The microglial sensome revealed by direct RNA sequencing. Nat Neurosci (2013) 2.73

A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem (2009) 2.37

TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell (2015) 2.15

A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep (2013) 1.92

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83

Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro (2010) 1.58

How do immune cells support and shape the brain in health, disease, and aging? J Neurosci (2013) 1.51

Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem (2009) 1.34

Systems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers. Mol Syst Biol (2012) 1.27

Inflammasome activation and IL-1β/IL-18 processing are influenced by distinct pathways in microglia. J Neurochem (2011) 1.10

Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology (2012) 1.07

Eat-me signals: keys to molecular phagocyte biology and "appetite" control. J Cell Physiol (2012) 1.04

CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun (2010) 0.99

TREM2 Protein Expression Changes Correlate with Alzheimer's Disease Neurodegenerative Pathologies in Post-Mortem Temporal Cortices. Brain Pathol (2014) 0.98

Neurobiology of microglial action in CNS injuries: receptor-mediated signaling mechanisms and functional roles. Prog Neurobiol (2014) 0.94

The immune response after hypoxia-ischemia in a mouse model of preterm brain injury. J Neuroinflammation (2014) 0.90

The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front Cell Neurosci (2015) 0.86

Modeling CNS microglia: the quest to identify predictive models. Drug Discov Today Dis Models (2008) 0.81

LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains. Orphanet J Rare Dis (2014) 0.81

Differential modulation of TREM2 protein during postnatal brain development in mice. PLoS One (2013) 0.79

Strategic applications of gene expression: from drug discovery/development to bedside. AAPS J (2013) 0.77

Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease. Neurogenetics (2015) 0.77

Regulation of microglial survival and proliferation in health and diseases. Semin Immunol (2016) 0.76

Microglia - the brain's busy bees. F1000Prime Rep (2013) 0.76

TREM-2 serves as a negative immune regulator through Syk pathway in an IL-10 dependent manner in lung cancer. Oncotarget (2016) 0.75

Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains. Mol Neurodegener (2016) 0.75

The putative role of environmental aluminium in the development of chronic neuropathology in adults and children. How strong is the evidence and what could be the mechanisms involved? Metab Brain Dis (2017) 0.75

TREM2 in Neurodegenerative Diseases. Mol Neurodegener (2017) 0.75

Articles cited by this

Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol (2000) 5.37

Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet (2002) 4.06

Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39

A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J Exp Med (2001) 3.18

Selective stimulation of astrocyte calcium in situ does not affect neuronal excitatory synaptic activity. Neuron (2007) 3.15

Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest (2003) 2.79

The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology (2005) 2.77

TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis. PLoS Med (2007) 2.62

Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity (1998) 2.54

Mature microglia resemble immature antigen-presenting cells. Glia (1998) 2.28

The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today (2000) 2.09

Role of ITAM-containing adapter proteins and their receptors in the immune system and bone. Immunol Rev (2005) 2.08

Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol (2007) 2.08

Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem (2002) 2.00

Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis. Eur J Immunol (2007) 1.88

Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J Exp Med (2003) 1.80

Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family. Eur J Immunol (2001) 1.78

Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res Brain Res Rev (2005) 1.73

Pattern recognition by TREM-2: binding of anionic ligands. J Immunol (2003) 1.73

Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects. Cell Mol Neurobiol (2004) 1.44

Myeloid development is selectively disrupted in PU.1 null mice. Blood (1998) 1.33

Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse. J Neurosci (2004) 1.29

Microglia and the control of autoreactive T cell responses. Neurochem Int (2006) 1.28

Nasu-Hakola syndrome: polycystic lipomembranous osteodysplasia with sclerosing leucoencephalopathy and presenile dementia. J Med Genet (1997) 1.24

The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res (2006) 1.24

Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol Dis (2005) 1.14

Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am J Pathol (2005) 1.11

Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells. Int Immunol (2002) 0.99

The role of the DAP12 signal in mouse myeloid differentiation. J Immunol (2000) 0.97

Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins. Mol Psychiatry (2003) 0.94

Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: continuous shuttling to and from the plasma membrane regulated by cell stimulation. Neuroscience (2006) 0.92

Transcript profiles of dendritic cells of PLOSL patients link demyelinating CNS disorders with abnormalities in pathways of actin bundling and immune response. J Mol Med (Berl) (2007) 0.89

Articles by these authors

Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia. J Neurochem (2002) 2.00

CD4-positive T cell-mediated neuroprotection requires dual compartment antigen presentation. J Neurosci (2004) 1.71

Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease. ASN Neuro (2010) 1.58

C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment. Blood (2007) 1.52

Conformational flexibility in the flap domains of ligand-free HIV protease. Acta Crystallogr D Biol Crystallogr (2007) 1.36

Virtual screening for HIV protease inhibitors: a comparison of AutoDock 4 and Vina. PLoS One (2010) 1.35

Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J Neurochem (2009) 1.34

Regulation of neutrophil and eosinophil secondary granule gene expression by transcription factors C/EBP epsilon and PU.1. Blood (2002) 1.32

The transcription factor encyclopedia. Genome Biol (2012) 1.28

Microglia and the control of autoreactive T cell responses. Neurochem Int (2006) 1.28

Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor. J Biol Chem (2004) 1.24

Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology (2007) 1.18

Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J Biol Chem (2003) 1.18

Is resistance futile? Curr Drug Targets Infect Disord (2003) 1.14

Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. J Cell Sci (2009) 1.11

Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment. Mol Ther (2012) 1.10

Targeting and hematopoietic suppression of human CD34+ cells by measles virus. J Virol (2002) 1.10

The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood (2004) 1.09

P2X4 receptors in activated C8-B4 cells of cerebellar microglial origin. J Gen Physiol (2010) 1.07

Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood (2014) 1.06

Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease. J Neurosci (2012) 1.03

PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells. Blood (2012) 1.03

Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10. J Immunol (2002) 1.03

CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun (2010) 1.00

Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses. J Virol (2006) 1.00

CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun (2010) 0.99

Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3. Retrovirology (2004) 0.97

Accessory mutations maintain stability in drug-resistant HIV-1 protease. J Mol Biol (2011) 0.96

The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes (2006) 0.96

HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. Br J Haematol (2008) 0.95

The death-associated protein kinase 2 is up-regulated during normal myeloid differentiation and enhances neutrophil maturation in myeloid leukemic cells. J Leukoc Biol (2007) 0.95

Small molecule regulation of protein conformation by binding in the Flap of HIV protease. ACS Chem Biol (2013) 0.94

Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. J Mol Biol (2005) 0.93

A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. J Med Chem (2008) 0.92

Modulation of drug resistance by artificial transcription factors. Mol Cancer Ther (2008) 0.91

NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. J Neuroimmune Pharmacol (2006) 0.91

Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. J Neurosci (2007) 0.90

CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation. Mol Immunol (2010) 0.88

The proteome of mouse brain microvessel membranes and basal lamina. J Cereb Blood Flow Metab (2011) 0.87

Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3. Retrovirology (2007) 0.87

Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3. J Virol (2004) 0.87

Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system. J Virol (2006) 0.87

Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. Biochem J (2010) 0.87

Inhibition of GATE-16 attenuates ATRA-induced neutrophil differentiation of APL cells and interferes with autophagosome formation. Biochem Biophys Res Commun (2013) 0.87

A cleavage enzyme-cytometric bead array provides biochemical profiling of resistance mutations in HIV-1 Gag and protease. Biochemistry (2011) 0.86

Switching-on survival and repair response programs in islet transplants by bone marrow-derived vasculogenic cells. Diabetes (2008) 0.86

Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia (2006) 0.86

Rapid deep sequencing of patient-derived HIV with ion semiconductor technology. J Virol Methods (2013) 0.85

LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent. Brain Behav Immun (2011) 0.85

Identification of HIV-1 inhibitors targeting the nucleocapsid protein. J Med Chem (2012) 0.85

Induction of Golli-MBP expression in CNS macrophages during acute LPS-induced CNS inflammation and experimental autoimmune encephalomyelitis (EAE). ScientificWorldJournal (2007) 0.85

Transcriptional regulation of MIR29B by PU.1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells. Br J Haematol (2011) 0.84

Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1. Curr Top Microbiol Immunol (2015) 0.81

A specific protein disorder catalyzer of HIV-1 Nef. Bioorg Med Chem (2011) 0.81

Computational analysis reveals increased blood deposition following repeated mild traumatic brain injury. Neuroimage Clin (2012) 0.81

Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease. J Virol (2010) 0.81

The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL. J Leukoc Biol (2013) 0.80

Glial cells as primary therapeutic targets for epilepsy. Neurochem Int (2013) 0.80

Induction and effector phase of allergic lung inflammation is independent of CCL21/CCL19 and LT-beta. Int J Med Sci (2009) 0.80

BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation. Exp Hematol Oncol (2012) 0.80

Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134. Proc Natl Acad Sci U S A (2009) 0.79

Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells. Stem Cells (2015) 0.79

Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease. Acta Crystallogr D Biol Crystallogr (2011) 0.78

Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores. Virology (2012) 0.78

When the tail can't wag the dog: the implications of CNS-intrinsic initiation of neuroinflammation. ASN Neuro (2009) 0.78

The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients. Br J Haematol (2012) 0.78

Role of the mammalian target of rapamycin pathway in lentiviral vector transduction of hematopoietic stem cells. Curr Opin Hematol (2015) 0.75

The Response to Burn Injury in Mice With Human Hematolymphoid Systems. Ann Surg (2016) 0.75

Preface. Curr Top Microbiol Immunol (2015) 0.75

A novel mRNA expressed along brain ventricles. Brain Res Gene Expr Patterns (2002) 0.75